1. Cronin CM, Sallan SE (1981) Early results of the antiemetic activity of intramuscular levonantradol. In: Poster DS, Penta JS, Bruno S (eds) Treatment of cancer chemotherapy-induced nausea and vomiting. Masson, New York, p 137
2. Gralla RJ, Itri LM, Pisko SE, Squillante AE, Kelsen DP, Braun DW, Bordin LA, Braun TJ, Young CW (1981) Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. N Engl J Med 305: 905
3. Heim ME, Romer W, Queisser W (1981) Clinical experience with levonantradol hydrochloride in the prevention of cancer chemotherapy-induced nausea and vomiting. J Clin Pharmacol 21: 865
4. Hermann TS, Einhorn LH, Jones SE, Nagy C, Chester AB, Dean JC, Furnas B, Williams SD, Leigh SA, Dorr RT, Moon TE (1979) Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy. N Engl J Med 300: 1295
5. Higi M, Niederle N, Bremer K, Seeber S (1981) Antiemetic efficacy of the new tetrahydrocannabinol-derivative levonantradol in patients receiving cancer chemotherapy. In: Book of conference abstracts. UICC Conference on Clinical Oncology, Lausanne, p 55